Mohammad Jalili1, Maryam Bahreini1, Amin Doosti-Irani2, Rasoul Masoomi3, Mona Arbab1, Hadi Mirfazaelian4. 1. Department of Emergency Medicine, Tehran University of Medical Sciences, Tehran, Iran. 2. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 3. Department of Medical Educations, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Emergency Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: H-Mirfazaelian@sina.tums.ac.ir.
Abstract
OBJECTIVE: This meta-analysis of trials was conducted to evaluate the analgesic and side effects of ketamine-propofol combination (ketofol) in comparison to propofol in procedural sedation and analgesia (PSA). METHODS: Medline, EMBASE, Scopus, CINHAL, and Cochrane Central Register of Controlled Trials were searched for clinical trial. The administration complications were the key outcomes of interest. RESULT: Eighteen clinical trials that met our criteria were included in the analysis. Pooling of data showed that ketofol is significantly effective for reduction of respiratory complication and with relative risk (RR) of 0.31 in 14 trials (95% confidence interval [CI], 0.47-0.7; P = .001). Ketofol was also effective in reducing cardiovascular complications with hypotension RR of 0.11 in 9 trials (95% CI, 0.17-0.97; P = .04) and bradycardia RR of 0.47 in 8 trials (95% CI, 0.28-0.72; P = .008). The present study also showed that the summary of RR for psychomimetic complications was 1.95 in 13 trials were (95% CI, 0.79-4.81; P = .15) and for muscle rigidity was 0.52 for 2 trials (95% CI, 0.06-4.67; P = .56), and both were insignificant. In regard to nausea and vomiting, the RR was 1.23 in 12 trials (95% CI, 0.39-3.88; P = .72) and insignificant. CONCLUSION: This meta-analysis demonstrates good safety profile in cardiorespiratory problems and comparable rate of other complications with propofol in adult procedural sedation and analgesia.
OBJECTIVE: This meta-analysis of trials was conducted to evaluate the analgesic and side effects of ketamine-propofol combination (ketofol) in comparison to propofol in procedural sedation and analgesia (PSA). METHODS: Medline, EMBASE, Scopus, CINHAL, and Cochrane Central Register of Controlled Trials were searched for clinical trial. The administration complications were the key outcomes of interest. RESULT: Eighteen clinical trials that met our criteria were included in the analysis. Pooling of data showed that ketofol is significantly effective for reduction of respiratory complication and with relative risk (RR) of 0.31 in 14 trials (95% confidence interval [CI], 0.47-0.7; P = .001). Ketofol was also effective in reducing cardiovascular complications with hypotension RR of 0.11 in 9 trials (95% CI, 0.17-0.97; P = .04) and bradycardia RR of 0.47 in 8 trials (95% CI, 0.28-0.72; P = .008). The present study also showed that the summary of RR for psychomimetic complications was 1.95 in 13 trials were (95% CI, 0.79-4.81; P = .15) and for muscle rigidity was 0.52 for 2 trials (95% CI, 0.06-4.67; P = .56), and both were insignificant. In regard to nausea and vomiting, the RR was 1.23 in 12 trials (95% CI, 0.39-3.88; P = .72) and insignificant. CONCLUSION: This meta-analysis demonstrates good safety profile in cardiorespiratory problems and comparable rate of other complications with propofol in adult procedural sedation and analgesia.
Authors: Jocelyn R Grunwell; Curtis Travers; Anne G Stormorken; Patricia D Scherrer; Corrie E Chumpitazi; Jana A Stockwell; Mark G Roback; Joseph Cravero; Pradip P Kamat Journal: Pediatr Crit Care Med Date: 2017-08 Impact factor: 3.624
Authors: Silvia Schönenberger; Dorothea Weber; Matthias N Ungerer; Johannes Pfaff; Simon Schieber; Lorenz Uhlmann; Pia Heidenreich; Martin Bendszus; Meinhard Kieser; Wolfgang Wick; Markus A Möhlenbruch; Peter A Ringleb; Julian Bösel Journal: Neurocrit Care Date: 2019-08 Impact factor: 3.210
Authors: Rhodri Saunders; Jason A Davis; Peter Kranke; Rachel Weissbrod; David K Whitaker; Jenifer R Lightdale Journal: Ther Clin Risk Manag Date: 2018-02-28 Impact factor: 2.423
Authors: Qiu Qiu; Liting Sun; Xiao-Min Wang; Amy C Y Lo; Kar Lok Wong; Pan Gu; Sau Ching Stanley Wong; Chi Wai Cheung Journal: Mol Pain Date: 2017 Jan-Dec Impact factor: 3.395